Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 4,393–4,400 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Zevra Therapeutics Inc. ACER-001 Maple Syrup Urine Disease (MSUD) Phase 2a Trial Planned Oral Genetic Disorder
Zevra Therapeutics Inc. Osanetant (ACER-801) induced Vasomotor Symptoms (iVMS) associated with menopause Phase 2a Clinical Pause Oral Women's Health
Zevra Therapeutics Inc. ACER-001 Maple Syrup Urine Disease (MSUD) Phase 2a Trial Planned Oral Genetic Disorder
Zevra Therapeutics Inc. Osanetant (ACER-801) induced Vasomotor Symptoms (iVMS) associated with menopause Phase 2a Clinical Pause Oral Women's Health
Zura Bio Limited Torudokimab (ZB-880) Asthma Phase 2/3 Ongoing Intravenous Respiratory
Zura Bio Limited Tibulizumab (LY3090106) Primary Sjogren's Syndrome Phase 2/3 Withdrawn Intravenous Immunology
Zura Bio Limited Tibulizumab (ZB-106) - (TibuSURE) Systemic Sclerosis Phase 2 Enrollment Initiation Intravenous Immunology
Zura Bio Limited Tibulizumab (ZB-106) - (TibuSHIELD) Hidradenitis Suppurativa Phase 2 Enrollment Initiation Intravenous Immunology: Anti-TNF